Tag: Prescription Drugs
FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
Approval is for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative disease
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
1,188,277 deaths could potentially be prevented over 12 months with optimal implementation of quadruple guideline-directed medical therapy
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
Longer progression-free survival seen with nivolumab + doxorubicin, vinblastine, and dacarbazine (AVD) versus brentuximab vedotin + AVD
15.5 Million Adults Had Current ADHD Diagnosis in 2023
Of the about one-third receiving stimulant medication, 71.5 percent had difficulty filling prescription due to unavailability
American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid Shortage
Tips include strategies for conserving fluids, cutting waste
FDA Approves Hympavzi for Hemophilia
Approval is for prophylactic treatment and targets protein in the blood clotting process
Availability, Timeliness of Availability of New Cancer Drugs Vary
More launches seen in association with higher Gross National Income per capita; shorter delays linked to cancer incidence
Dronabinol Safe, Effective for Alzheimer Disease With Agitation
Authors are optimistic about the 'repurposing' of FDA-approved dronabinol
Lamotrigine, Mexiletine Show Similar Benefits for Nondystrophic Myotonias
No serious adverse events seen with either treatment in eight-week crossover trial,
Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa
Clinically meaningful efficacy outcomes observed at one year maintained to two years of treatment